Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 61 non-cytoplasmic 62 82 transmembrane 83 92 cytoplasmic 93 112 transmembrane 113 117 non-cytoplasmic 118 140 transmembrane 141 151 cytoplasmic 152 174 transmembrane 175 193 non-cytoplasmic 194 213 transmembrane 214 273 cytoplasmic 274 297 transmembrane 298 314 non-cytoplasmic 315 334 transmembrane 335 341 cytoplasmic 342 365 transmembrane 366 376 non-cytoplasmic 377 404 transmembrane 405 415 cytoplasmic 416 439 transmembrane 440 444 non-cytoplasmic 445 465 transmembrane 466 478 cytoplasmic
Input: >CCNA_00857 MASVSNAGPSAGMSADGGKVNMTFVAAIVAVATIGGFMFGYDSGVINGTQEGLESAFNLS KLGTGLNVGAILIGCAIGAFAAGRLADVWGRRTVMIISALLFVISAIGTGAAESSIVFII FRLIGGLGVGAASVLCPVYISEVTPANIRGRLSSVQQIMIITGLTGAFVANYALAHTAGS STAEFWLGLPAWRWMFWMQIIPAGVFFLCLLGIPESPRYLVAKGKDAQAEAILSRLFGAG QGAKKVEEIRASLSADHKPTFSDLLDPTTKKLRVILWAGLVLAVFQQLVGINIVFYYGSV LWQSVGFTEDDSLKINILSGTLSILACLLAIGLIDKIGRKPLLLIGSAGMAVTLGVLTWC FSTATTVNGALTLGDQIGLTALIAANLYVIFFNLSWGPVMWVMLGEMFPNQMRGSALAVC GFAQWIANFAISVSFPALAAASLPMTYGFYALSAVVSFFLVQKLVHETRGKELEAMQG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server